Difference between actual and published PK parameters [Study As­sess­ment]

posted by dshah  – India, 2022-02-15 16:26 (1596 d 04:32 ago) – Posting: # 22784
Views: 6,636

Dear Loky do!

❝ does this biphasic nature affect the practical obtained half life of the drug? and is this nature could affect the drug variability?


The biphasic nature (compartmental analysis) would not affect your outcome for BE as NCA is recommended by regulatory bodies. Although as per AusPAR- there is no significant impact of age and Race, your half-life is different than the reported one. Kindly refer pg 27-34 of AusPAR.

Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
315 visitors (0 registered, 315 guests [including 127 identified bots]).
Forum time: 21:58 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5